147
Participants
Start Date
July 15, 2019
Primary Completion Date
May 25, 2022
Study Completion Date
May 25, 2022
Behavioral Treatment
Behavioral treatment (BT) for weight loss includes diet and physical activity recommendations and behavior therapy strategies. All participants will complete an initial 4-week BT run-in, delivered in individual, 20-30 minute weekly sessions. After the end of the run-in, participants will be offered an additional 24 weeks of 20-30 minute individual BT sessions, occurring weekly for the first 12 weeks and every other week for the last 12 weeks (total of 18 visits).
Placebo
The study medication (placebo or phentermine 15.0 mg) is a once-daily self-administered pill.
Phentermine 15 MG
The study medication (placebo or phentermine 15.0 mg) is a once-daily self-administered pill.
University of Pennsylvania Center for Weight and Eating Disorders, Philadelphia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Pennsylvania
OTHER